FactorPad
Build a Better Process

Stock Risk Measures for Acceleron Pharma Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 41 for XLRN below.

/ factorpad.com / stocks / f72hqf.html


An ad-free and cookie-free webpage by FactorPad


XLRN Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Acceleron Pharma Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how XLRN stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f72hqf.html


XLRN stock risk
ACCELERON PHARMA INC stock beta
XLRN risk report
XLRN f72hqf
XLRN risk analysis
XLRN volatility
ACCELERON PHARMA INC credit risk
XLRN liquidity risk
XLRN leverage
XLRN valuation
XLRN systematic risk
XLRN specific risk
ACCELERON PHARMA INC volatility
XLRN analysis
XLRN financial ratio

This is a new resource, spread the word, tell a friend